Sagimet Biosciences (SGMT) Retained Earnings (2022 - 2026)

Sagimet Biosciences' Retained Earnings history runs 5 years deep, the most recent figure standing at -$357.0 million for Q1 2026.

• In Q1 2026, Retained Earnings fell 295140.5% year-over-year to -$357.0 million; the TTM figure through Mar 2026 stood at -$357.0 million (down 295140.5% YoY), while the FY2025 annual figure was -$346.3 million, down 150686.52% from the prior year.
• Retained Earnings was -$357.0 million for Q1 2026 at Sagimet Biosciences, down from -$346.3 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $230000.0 in Q4 2024 to a low of -$357.0 million in Q1 2026.
• Historically, Retained Earnings has averaged -$199.8 million across 5 years, with a median of -$241.6 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings surged 666.67% in 2024, then slumped 1408160.87% in 2025.
• A 5-year view of Retained Earnings shows it stood at -$221.9 million in 2022, then soared by 100.01% to $30000.0 in 2023, then soared by 666.67% to $230000.0 in 2024, then sank by 150686.52% to -$346.3 million in 2025, then fell by 3.07% to -$357.0 million in 2026.
• The last three Retained Earnings figures came in at -$357.0 million (Q1 2026), -$346.3 million (Q4 2025), and -$336.8 million (Q3 2025), per Business Quant data.